Abstract:Objective: This study aimed to distinguish between healthy controls and patients with OSAHS regarding homocysteine (HCY) levels and investigate how individuals with OSAHS respond to continuous positive airway pressure ventilation (CPAP) in terms of serum and plasma HCY levels. Methods: To ascertain published articles about OSAHS, an exhaustive search was performed across medical databases, encompassing PubMed, Web of Science, EMBASE, CNKI, and Cochrane Library, until January 2, 2024. This study reviewed the literature regarding HCY levels in individuals with OSAHS and control groups, HCY levels under pre- and post-CPAP treatment, the Pearson/Spearman correlation coefficients between HCY levels and apnea-hypopnea index (AHI), and the hazard ratio (HR) of HCY levels concerning the occurrence of major adverse cerebrocardiovascular events (MACCEs) in patients with OSAHS. Meta-analyses were performed using weighted mean difference (WMD), correlation coefficients, and HR as effect variables. The statistical analysis was conducted using the R 4.1.2 and STATA 11.0 software packages. Results: In total, 33 articles were selected for the final analysis. The OSAHS group exhibited significantly higher serum/plasma HCY levels than the control group (WMD = 4.25 μmol/L, 95% CI: 2.60–5.91, P < 0.001), particularly among individuals with moderate and severe OSAHS. Additionally, subgroup analysis using mean age, ethnicity, mean body mass index, and study design type unveiled significantly elevated levels of HCY in the serum/plasma of the OSAHS group compared to the control group. CPAP treatment can significantly decrease serum/plasma HCY levels in patients with OSAHS. Moreover, elevated HCY levels in individuals with OSAHS could be one of the risk factors for MACCEs (adjusted HR = 1.68, 95% CI = 1.10–2.58, P = 0.017). AHI scores show a positive correlation with serum/plasma HCY levels. Conclusion: Patients with OSAHS had elevated serum/plasma HCY levels compared to healthy controls; however, CPAP therapy dramatically decreased HCY levels in patients with OSAHS. In patients with OSAHS, elevated HCY levels were linked with an increased risk of MACCEs, and HCY was positively connected with AHI values. HCY levels may serve as a useful clinical indicator for determining the severity and efficacy of OSAHS treatments. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42024498806.

Association Between Serum Homocysteine and Oxidative Stress in Elderly Patients with Obstructive Sleep Apnea/hypopnea Syndrome.

Research on serum homocysteine level and its relationship with oxidative stress in elderly patients with obstructive sleep apnea/hypopnea syndrome and the inner mechanism

[Relationship Between Serum Homocysteine Level and Oxidative Stress in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome].

Correlation of serum 8-hydroxydeoxyguanylate level with disease severity and oxidative stress in osahs patients

Association between elevated homocysteine levels and obstructive sleep apnea hypopnea syndrome: a systematic review and updated meta-analysis

Changes in homocysteine levels in patients with ischemic cerebral disease and obstructive sleep apnea-hypopnea syndrome

Homocysteine Level in Patients with Obstructive Sleep Apnea/hypopnea Syndrome and the Impact of Continuous Positive Airway Pressure Treatment

Neurocognitive Impairment is Correlated with Oxidative Stress in Patients with Moderate-to-severe Obstructive Sleep Apnea Hypopnea Syndrome

Correlation Between Oxidative Stress and Obstructive Sleep Apnea-Hypopnea Syndrome

Study about the change of lipid metabolism in patients of obstructive sleep apneahypopnea syndrome

Clinical and Polysomnographic Characteristics in Elderly Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Research on the Association Between Obstructive Sleep Apnea Hypopnea Syndrome Complicated With Coronary Heart Disease and Inflammatory Factors, Glycolipid Metabolism, Obesity, and Insulin Resistance

Peripheral blood oxidative stress markers for obstructive sleep apnea—a meta-analysis

Circulating markers of oxidative stress and risk of incident cardiovascular events in obstructive sleep apnea

Plasma Homocysteine and Autonomic Nervous Dysfunction: Association and Clinical Relevance in OSAS

The relationship between obstructive sleep apnea-hypopnea syndrome and blood uric acid levels

Influence of Obstructive Sleep Apnea hypopnea Syndrome on Cardiovascular Risk Factors

The Differences in Homocysteine Level Between Obstructive Sleep Apnea Patients and Controls: a Meta-Analysis.

Levels and clinical value of serum homocysteine and cystatin C in patients with obstructive sleep apnea syndrome

Association Cystatin C and Risk of Stroke in Elderly Patients With Obstructive Sleep Apnea: A Prospective Cohort Study

Study on depression and level of C-reactive protein in patients with obstructive sleep apnea-hypopnea syndrome